Also indexed as: Alendronic Acid, Biophosphonates,
Fosamax®
Alendronate is a member of the bisphosphonate family of drugs used to treat/prevent osteoporosis. It is also used to treat some bone
diseases and some cases of cancer that have spread to bones.
Summary of
Interactions with Vitamins, Herbs, and Foods
In some cases, a herb or supplement may appear in more than one category, which may seem
contradictory. For clarification, read the full article for details about the summarized
interactions.
Check: Other—Before taking any of these supplements or eating any of
these foods with your medication, read this article in full for details. |
Calcium
Magnesium
|
| Depletion or interference |
None known
|
| Side effect reduction/prevention |
None known
|
| Supportive interaction |
None known
|
| Reduced drug
absorption/bioavailability |
None known
|
| Adverse interaction |
None known
|
An asterisk (*) next to an item in the summary indicates that the
interaction is supported only by weak, fragmentary, and/or contradictory scientific
evidence.
Interactions with Dietary Supplements
Calcium
Calcium supplements may interfere with alendronate absorption.1 However, one
researcher suggested that addition of large amounts of supplemental calcium to alendronate
therapy in patients with bone metastases (with evidence of osteomalacia) related to prostate cancer might improve
the clinical outcome.2 Moreover, both calcium and alendronate are commonly used in
the treatment of osteoporosis in the same people. To prevent potential interactions,
alendronate should be taken two hours before or after calcium supplements.
Magnesium
Absorption of tiludronate, a drug related to alendronate, is reduced when taken with magnesium and/or aluminium-containing antacids.3 This
interaction has not yet been reported with alendronate. Until more is known, alendronate
should be taken two hours before or after magnesium and/or aluminium-containing antacids.
Interactions with Foods and Other Compounds
Food
Food, coffee, and orange juice significantly reduce absorption of alendronate.4
Alendronate should be taken with a large glass of plain water, upon arising in the morning,
and 30 minutes or more before any food, beverages, supplements, or other
medications.5 People taking alendronate should remain upright (do not lie down) for
30 minutes after taking the drug.6
References
(To view, roll mouse over heading; to hide, click on heading)
1. Threlkeld DS, ed. Hormones, Bisphosphonates. InFacts and
Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Jul 1998, 134r.
2. Adami S. Bisphosphonates in prostate carcinoma. Cancer
1997;80:1674–9.
3. Threlkeld DS, ed. Hormones, Bisphosphonates. InFacts and
Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Jul 1998, 134r.
4. Gertz BJ, Holland SD, Kline WF, et al. Studies of the oral
bioavailability of alendronate. Clin Pharmacol Ther 1995;58:288–98.
5. Threlkeld DS, ed. Hormones, Bisphosphonates. InFacts and
Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Jul 1998, 134r.
6. Threlkeld DS, ed. Hormones, Bisphosphonates. InFacts and
Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Jul 1998, 134r.
Copyright © 2006 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Please read the
disclaimer about the limitations of the information provided here. Do NOT rely solely on
the information in this article.
Learn more about Healthnotes, the
company.
Learn more about the authors of Using Medicines
with Vitamins and Herbs
The information presented in Healthnotes is for informational purposes
only. It is based on scientific studies (human, animal, or in vitro), clinical
experience, or traditional usage as cited in each article. The results reported may not
necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over the counter medication is also available. Consult your doctor,
practitioner, and/or chemist for any health problem and before using any supplements or before
making any changes in prescribed medications. Information expires March 2007.